Skip to main content

Animations

MJFF Publications

3431 - 3440 of 6568 Results
Title
Year
  • Year
  • 2025
  • 2026
  • 2016
  • 2017
  • 2007
  • 2023
  • 2018
  • 2019
  • 2017
  • 2012
  • Summary Details
    OPEN
    Title: A validation study of the Clinician's Tardive Inventory (CTI)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptors
    Journal Name: Molecular Neurodegeneration Advances
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s44477-025-00016-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0482-0
    Citation Count: 128
  • Summary Details
    OPEN
    Title: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012
    Citation Count: 182
  • Summary Details
    OPEN
    Title: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy
    Journal Name: SLAS Discovery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nly056
    Citation Count: 37
  • Summary Details
    OPEN
    Title: The clinical significance of lower limb tremors
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.007
    Citation Count: 17
  • Summary Details
    OPEN
    Title: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's disease
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23547
    Citation Count: 52
  • Summary Details
    OPEN
    Title: 17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/969418
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.